@article{ba0c0c33f25b47c89a08158fb27c4ccf,
title = "Individual Ion Mass Spectrometry Enhances the Sensitivity and Sequence Coverage of Top-Down Mass Spectrometry",
abstract = "Charge detection mass spectrometry (CDMS) is mainly utilized to determine the mass of intact molecules. Previous applications of CDMS have determined the mass-to-charge ratio and the charge of large polymers, DNA molecules, and native protein complexes, from which corresponding mass values could be assigned. Recent advances have demonstrated that CDMS using an Orbitrap mass analyzer yields the reliable assignment of integer charge states that enables individual ion mass spectrometry (I2MS) and spectral output directly into the mass domain. Here I2MS analysis was extended to isotopically resolved fragment ions from intact proteoforms for the first time. With a radically different bias for ion readout, I2MS identified low-abundance fragment ions containing many hundreds of residues that were undetectable by standard Orbitrap measurements, leading to a doubling in the sequence coverage of triosephosphate isomerase. Thus MS/MS with the detection of individual ions (MS/I2MS) provides a far greater ability to detect high mass fragment ions and exhibits strong complementarity to traditional spectral readout in this, its first application to top-down mass spectrometry.",
author = "Kafader, {Jared O.} and Durbin, {Kenneth R.} and Melani, {Rafael D.} and {Des Soye}, {Benjamin J.} and Schachner, {Luis F.} and Senko, {Michael W.} and Compton, {Philip D.} and Kelleher, {Neil L.}",
note = "Funding Information: This work was funded by the Intensifying Innovation program from Thermo Fisher Scientific and was carried out in collaboration with the National Resource for Translational and Developmental Proteomics under Grant P41 GM108569 from the National Institute of General Medical Sciences, National Institutes of Health with additional support from the Sherman Fairchild Foundation. J.O.K. received additional funding from the American Society for Mass Spectrometry from a 2019 Post-Doctoral Career Development Award. L.F.S. is a Gilliam Fellow of the Howard Hughes Medical Institute. We thank Ryan Fellers and Bryan Early for their software development support. Funding Information: This work was funded by the Intensifying Innovation program from Thermo Fisher Scientific and was carried out in collaboration with the National Resource for Translational and Developmental Proteomics under Grant P41 GM108569 from the National Institute of General Medical Sciences, National Institutes of Health with additional support from the Sherman Fairchild Foundation. J.O.K. received additional funding from the American Society for Mass Spectrometry from a 2019 Post-Doctoral Career Development Award. L.F.S. is a Gilliam Fellow of the Howard Hughes Medical Institute. We thank Ryan Fellers and Bryan Early for their software development support. Publisher Copyright: Copyright {\textcopyright} 2020 American Chemical Society.",
year = "2020",
month = mar,
day = "6",
doi = "10.1021/acs.jproteome.9b00797",
language = "English (US)",
volume = "19",
pages = "1346--1350",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "3",
}